BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jørgensen KK, Grzyb K, Lundin KE, Clausen OP, Aamodt G, Schrumpf E, Vatn MH, Boberg KM. Inflammatory bowel disease in patients with primary sclerosing cholangitis: clinical characterization in liver transplanted and nontransplanted patients. Inflamm Bowel Dis. 2012;18:536-545. [PMID: 21456044 DOI: 10.1002/ibd.21699] [Cited by in Crossref: 73] [Cited by in F6Publishing: 69] [Article Influence: 6.6] [Reference Citation Analysis]
Number Citing Articles
1 Karlsen TH, Boberg KM. Update on primary sclerosing cholangitis. J Hepatol. 2013;59:571-582. [PMID: 23603668 DOI: 10.1016/j.jhep.2013.03.015] [Cited by in Crossref: 77] [Cited by in F6Publishing: 69] [Article Influence: 8.6] [Reference Citation Analysis]
2 Nordenvall C, Olén O, Johan Nilsson P, Ekbom A, Bottai M, Myrelid P, Bergquist A. Restorative Surgery in Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis Following a Colectomy. Inflammatory Bowel Diseases 2018;24:624-32. [DOI: 10.1093/ibd/izx048] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
3 Park SH, Yang SK, Park SK, Kim JW, Yang DH, Jung KW, Kim KJ, Ye BD, Byeon JS, Myung SJ, Kim JH. Atypical distribution of inflammation in newly diagnosed ulcerative colitis is not rare. Can J Gastroenterol Hepatol. 2014;28:125-130. [PMID: 24619632 DOI: 10.1155/2014/834512] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
4 Rossi RE, Conte D, Massironi S. Primary sclerosing cholangitis associated with inflammatory bowel disease: an update. European Journal of Gastroenterology & Hepatology 2016;28:123-31. [DOI: 10.1097/meg.0000000000000532] [Cited by in Crossref: 32] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
5 Vatn MH, Sandvik AK. Inflammatory bowel disease. Scandinavian Journal of Gastroenterology 2015;50:748-62. [DOI: 10.3109/00365521.2015.1033000] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
6 Barnes EL, Holubar SD, Herfarth HH. Systematic Review and Meta-analysis of Outcomes After Ileal Pouch-anal Anastomosis in Primary Sclerosing Cholangitis and Ulcerative Colitis. J Crohns Colitis 2021;15:1272-8. [PMID: 33544128 DOI: 10.1093/ecco-jcc/jjab025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Nepal S, Navaneethan U, Bennett AE, Shen B. De novo inflammatory bowel disease and its mimics after organ transplantation. Inflamm Bowel Dis. 2013;19:1518-1527. [PMID: 23656896 DOI: 10.1097/mib.0b013e3182813365] [Cited by in Crossref: 23] [Cited by in F6Publishing: 2] [Article Influence: 2.9] [Reference Citation Analysis]
8 Chung BK, Henriksen EKK, Jørgensen KK, Karlsen TH, Hirschfield GM, Liaskou E. Gut and Liver B Cells of Common Clonal Origin in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease. Hepatol Commun 2018;2:956-67. [PMID: 30094406 DOI: 10.1002/hep4.1200] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
9 Williamson KD, Chapman RW. Primary sclerosing cholangitis: a clinical update. Br Med Bull. 2015;114:53-64. [PMID: 25981516 DOI: 10.1093/bmb/ldv019] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
10 Nakazawa T, Naitoh I, Hayashi K, Sano H, Miyabe K, Shimizu S, Joh T. Inflammatory bowel disease of primary sclerosing cholangitis: A distinct entity? World J Gastroenterol 2014; 20(12): 3245-3254 [PMID: 24696608 DOI: 10.3748/wjg.v20.i12.3245] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
11 Haapamäki J, Tenca A, Sintonen H, Barner-rasmussen N, Färkkilä MA. Health-related quality of life among patients with primary sclerosing cholangitis. Liver Int 2015;35:2194-201. [DOI: 10.1111/liv.12775] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
12 Pena Polanco NA, Levy C, Martin EF. Cholestatic Liver Diseases After Liver Transplant. Clinics in Liver Disease 2017;21:403-20. [DOI: 10.1016/j.cld.2016.12.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
13 Jiang X, Karlsen TH. Genetics of primary sclerosing cholangitis and pathophysiological implications. Nat Rev Gastroenterol Hepatol 2017;14:279-95. [DOI: 10.1038/nrgastro.2016.154] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 9.2] [Reference Citation Analysis]
14 Jendrek ST, Gotthardt D, Nitzsche T, Widmann L, Korf T, Michaels MA, Weiss KH, Liaskou E, Vesterhus M, Karlsen TH, Mindorf S, Schemmer P, Bär F, Teegen B, Schröder T, Ehlers M, Hammers CM, Komorowski L, Lehnert H, Fellermann K, Derer S, Hov JR, Sina C. Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitis. Gut 2017;66:137-44. [PMID: 27406039 DOI: 10.1136/gutjnl-2016-311739] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 5.2] [Reference Citation Analysis]
15 Fousekis FS, Theopistos VI, Mitselos IV, Skamnelos A, Kavvadias A, Katsanos KH, Christodoulou DK. Specific Features of Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis. J Clin Med Res 2019;11:81-8. [PMID: 30700999 DOI: 10.14740/jocmr3680] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
16 Lee WS, Karthik SV, Ng RT, Ong SY, Ong C, Chiou FK, Wong SY, Quak SH, Aw MM. Characteristics and outcome of primary sclerosing cholangitis associated with inflammatory bowel disease in Asian children. Pediatr Neonatol 2019;60:396-404. [PMID: 31409456 DOI: 10.1016/j.pedneo.2018.09.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
17 de Krijger M, Visseren T, Wildenberg ME, Hooijer GKJ, Verstegen MMA, van der Laan LJW, de Jonge WJ, Verheij J, Ponsioen CY. Characterization of gut-homing molecules in non-endstage livers of patients with primary sclerosing cholangitis and inflammatory bowel disease. J Transl Autoimmun 2020;3:100054. [PMID: 32743534 DOI: 10.1016/j.jtauto.2020.100054] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Pollheimer MJ, Halilbasic E, Fickert P, Trauner M. Pathogenesis of primary sclerosing cholangitis. Best Pract Res Clin Gastroenterol 2011;25:727-39. [PMID: 22117638 DOI: 10.1016/j.bpg.2011.10.009] [Cited by in Crossref: 72] [Cited by in F6Publishing: 65] [Article Influence: 7.2] [Reference Citation Analysis]
19 Schrumpf E, Boberg KM, Karlsen TH. Primary sclerosing cholangitis - the Norwegian experience. Scand J Gastroenterol 2015;50:781-96. [PMID: 25866138 DOI: 10.3109/00365521.2015.1028996] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
20 De Angelis P, Tambucci R, Romeo E, Rea F, Caloisi C, Caldaro T, di Abriola GF, Foschia F, Torroni F, Monti L, Dall'Oglio L. Does an isolated benign choledochal stricture hide a PSC? J Pediatr Surg 2013;48:1006-11. [PMID: 23701774 DOI: 10.1016/j.jpedsurg.2013.02.020] [Reference Citation Analysis]
21 Palmela C, Peerani F, Castaneda D, Torres J, Itzkowitz SH. Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific Features. Gut Liver. 2018;12:17-29. [PMID: 28376583 DOI: 10.5009/gnl16510] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 11.0] [Reference Citation Analysis]
22 Yano K, Moroi R, Shiga H, Tarasawa K, Shimoyama Y, Kuroha M, Hamada S, Kakuta Y, Fushimi K, Fujimori K, Kinouchi Y, Masamune A. Analysis of the disease activity of ulcerative colitis with and without concomitant primary sclerosing cholangitis: An investigation using a nationwide database in Japan. JGH Open 2022;6:50-6. [PMID: 35071788 DOI: 10.1002/jgh3.12693] [Reference Citation Analysis]
23 Van Der Have M, Oldenburg B. Is Ulcerative Colitis Associated With Primary Sclerosing Cholangitis an Undertreated Condition? Inflammatory Bowel Diseases 2020;26:780-1. [DOI: 10.1093/ibd/izz211] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
24 Navaneethan U, Choudhary M, Venkatesh PG, Lashner BA, Remzi FH, Shen B, Kiran RP. The effects of liver transplantation on the clinical course of colitis in ulcerative colitis patients with primary sclerosing cholangitis. Aliment Pharmacol Ther. 2012;35:1054-1063. [PMID: 22428731 DOI: 10.1111/j.1365-2036.2012.05067.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 15] [Article Influence: 0.4] [Reference Citation Analysis]
25 Liu J, Dlugosz A, Neumann H. Beyond white light endoscopy: The role of optical biopsy in inflammatory bowel disease. World J Gastroenterol 2013; 19(43): 7544-7551 [PMID: 24282344 DOI: 10.3748/wjg.v19.i43.7544] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
26 Rocha HC, Vilela EG. Clinical aspects and prognosis of patients with inflammatory bowel disease associated with autoimmune liver diseases. Gastroenterol Hepatol 2021:S0210-5705(21)00153-9. [PMID: 34023469 DOI: 10.1016/j.gastrohep.2021.03.011] [Reference Citation Analysis]
27 Shah A, Macdonald GA, Morrison M, Holtmann G. Targeting the Gut Microbiome as a Treatment for Primary Sclerosing Cholangitis: A Conceptional Framework. Am J Gastroenterol 2020;115:814-22. [PMID: 32250997 DOI: 10.14309/ajg.0000000000000604] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
28 Gelley F, Miheller P, Péter A, Telkes G, Nemes B. Activity of ulcerative colitis before and after liver transplantation in primary sclerosing cholangitis: the Hungarian experience. Transplant Proc. 2012;44:2164-2165. [PMID: 22974943 DOI: 10.1016/j.transproceed.2012.07.098] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
29 Trivedi PJ, Chapman RW. PSC, AIH and overlap syndrome in inflammatory bowel disease. Clin Res Hepatol Gastroenterol. 2012;36:420-436. [PMID: 22306055 DOI: 10.1016/j.clinre.2011.10.007] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
30 European Society of Gastrointestinal Endoscopy, European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; European Association for the Study of the Liver. Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline. J Hepatol. 2017;66:1265-1281. [PMID: 28427764 DOI: 10.1016/j.jhep.2017.02.013] [Cited by in Crossref: 47] [Cited by in F6Publishing: 35] [Article Influence: 9.4] [Reference Citation Analysis]
31 Eaton JE, Talwalkar JA. Primary Sclerosing Cholangitis: Current and Future Management Strategies. Curr Hepat Rep 2013;12:28-36. [PMID: 23682242 DOI: 10.1007/s11901-012-0155-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
32 Boonstra K, van Erpecum KJ, van Nieuwkerk KM, Drenth JP, Poen AC, Witteman BJ, Tuynman HA, Beuers U, Ponsioen CY. Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease. Inflamm Bowel Dis. 2012;18:2270-2276. [PMID: 22407885 DOI: 10.1002/ibd.22938] [Cited by in Crossref: 121] [Cited by in F6Publishing: 108] [Article Influence: 12.1] [Reference Citation Analysis]
33 Folseraas T, Liaskou E, Anderson CA, Karlsen TH. Genetics in PSC: what do the "risk genes" teach us? Clin Rev Allergy Immunol 2015;48:154-64. [PMID: 24736995 DOI: 10.1007/s12016-014-8417-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
34 Aranake-Chrisinger J, Dassopoulos T, Yan Y, Nalbantoglu I. Primary sclerosing cholangitis associated colitis: Characterization of clinical, histologic features, and their associations with liver transplantation. World J Gastroenterol 2020; 26(28): 4126-4139 [PMID: 32821074 DOI: 10.3748/wjg.v26.i28.4126] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Ricciuto A, Kamath BM, Griffiths AM. The IBD and PSC Phenotypes of PSC-IBD. Curr Gastroenterol Rep. 2018;20:16. [PMID: 29594739 DOI: 10.1007/s11894-018-0620-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
36 Floreani A, De Martin S, Secchi MF, Cazzagon N. Extrahepatic autoimmunity in autoimmune liver disease. European Journal of Internal Medicine 2019;59:1-7. [DOI: 10.1016/j.ejim.2018.10.014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
37 Hirschfield GM, Chapman RW, Karlsen TH, Lammert F, Lazaridis KN, Mason AL. The genetics of complex cholestatic disorders. Gastroenterology. 2013;144:1357-1374. [PMID: 23583734 DOI: 10.1053/j.gastro.2013.03.053] [Cited by in Crossref: 99] [Cited by in F6Publishing: 89] [Article Influence: 11.0] [Reference Citation Analysis]
38 Björnsson ES, Ekbom A. Scandinavian epidemiological research in gastroenterology and hepatology. Scand J Gastroenterol 2015;50:636-48. [PMID: 25881666 DOI: 10.3109/00365521.2015.1034168] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
39 Nabavi SF, Daglia M, Moghaddam AH, Habtemariam S, Nabavi SM. Curcumin and Liver Disease: from Chemistry to Medicine: Curcumin and liver disease…. Comprehensive Reviews in Food Science and Food Safety 2014;13:62-77. [DOI: 10.1111/1541-4337.12047] [Cited by in Crossref: 97] [Cited by in F6Publishing: 59] [Article Influence: 10.8] [Reference Citation Analysis]
40 Huang YQ. Advances in research of primary sclerosing cholangitis. Shijie Huaren Xiaohua Zazhi 2012; 20(31): 2978-2985 [DOI: 10.11569/wcjd.v20.i31.2978] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
41 Nakazawa T, Notohara K, Tazuma S, Tanaka A, Isayama H, Tsuyuguchi T, Mori T, Takikawa H. The 2016 diagnostic criteria for primary sclerosing cholangitis. J Gastroenterol 2017;52:838-44. [DOI: 10.1007/s00535-016-1286-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
42 de'Angelis N, Esposito F, Memeo R, Lizzi V, Martìnez-Pérez A, Landi F, Genova P, Catena F, Brunetti F, Azoulay D. Emergency abdominal surgery after solid organ transplantation: a systematic review. World J Emerg Surg 2016;11:43. [PMID: 27582783 DOI: 10.1186/s13017-016-0101-6] [Cited by in Crossref: 34] [Cited by in F6Publishing: 22] [Article Influence: 5.7] [Reference Citation Analysis]
43 Fevery J, Van Steenbergen W, Van Pelt J, Laleman W, Hoffman I, Geboes K, Vermeire S, Nevens F. Patients with large-duct primary sclerosing cholangitis and Crohn's disease have a better outcome than those with ulcerative colitis, or without IBD. Aliment Pharmacol Ther. 2016;43:612-620. [PMID: 26748470 DOI: 10.1111/apt.13516] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
44 Singh S, Loftus EV, Talwalkar JA. Inflammatory Bowel Disease after Liver Transplantation for Primary Sclerosing Cholangitis. American Journal of Gastroenterology 2013;108:1417-25. [DOI: 10.1038/ajg.2013.163] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 5.2] [Reference Citation Analysis]
45 Wiencke K, Boberg K. Current consensus on the management of primary sclerosing cholangitis. Clinics and Research in Hepatology and Gastroenterology 2011;35:786-91. [DOI: 10.1016/j.clinre.2011.04.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
46 Barberio B, Massimi D, Cazzagon N, Zingone F, Ford AC, Savarino EV. Prevalence of Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Gastroenterology 2021:S0016-5085(21)03412-0. [PMID: 34425093 DOI: 10.1053/j.gastro.2021.08.032] [Reference Citation Analysis]
47 Vo HD, Xu J, Rabinowitz SS, Fisher SE, Schwarz SM. The Liver in Pediatric Gastrointestinal Disease. Journal of Pediatric Gastroenterology & Nutrition 2014;59:288-99. [DOI: 10.1097/mpg.0000000000000444] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
48 de Krijger M, Wildenberg ME, de Jonge WJ, Ponsioen CY. Return to sender: Lymphocyte trafficking mechanisms as contributors to primary sclerosing cholangitis. J Hepatol 2019;71:603-15. [PMID: 31108158 DOI: 10.1016/j.jhep.2019.05.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
49 Schnitzler F, Friedrich M, Stallhofer J, Schönermarck U, Fischereder M, Habicht A, Karbalai N, Wolf C, Angelberger M, Olszak T, Beigel F, Tillack C, Göke B, Zachoval R, Denk G, Guba M, Rust C, Grüner N, Brand S. Solid Organ Transplantation in Patients with Inflammatory Bowel Diseases (IBD): Analysis of Transplantation Outcome and IBD Activity in a Large Single Center Cohort. PLoS One 2015;10:e0135807. [PMID: 26288187 DOI: 10.1371/journal.pone.0135807] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
50 Henriksen EKK, Jørgensen KK, Kaveh F, Holm K, Hamm D, Olweus J, Melum E, Chung BK, Eide TJ, Lundin KE, Boberg KM, Karlsen TH, Hirschfield GM, Liaskou E. Gut and liver T-cells of common clonal origin in primary sclerosing cholangitis-inflammatory bowel disease. Journal of Hepatology 2017;66:116-22. [DOI: 10.1016/j.jhep.2016.09.002] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 5.4] [Reference Citation Analysis]
51 Chapman R, Williamson K. Primary Sclerosing Cholangitis. The Digestive Involvement in Systemic Autoimmune Diseases. Elsevier; 2017. pp. 119-39. [DOI: 10.1016/b978-0-444-63707-9.00007-6] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
52 Wohl P, Hucl T, Drastich P, Kamenar D, Spicak J, Honsova E, Sticova E, Lodererova A, Matous J, Hill M, Wohl P, Kucera M. Epithelial markers of colorectal carcinogenesis in ulcerative colitis and primary sclerosing cholangitis. World J Gastroenterol 2013; 19(14): 2234-2241 [PMID: 23599650 DOI: 10.3748/wjg.v19.i14.2234] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
53 Kummen M, Schrumpf E, Boberg KM. Liver abnormalities in bowel diseases. Best Pract Res Clin Gastroenterol. 2013;27:531-542. [PMID: 24090940 DOI: 10.1016/j.bpg.2013.06.013] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
54 Isene R, Bernklev T, Høie O, Munkholm P, Tsianos E, Stockbrügger R, Odes S, Palm Ø, Småstuen M, Moum B; EC-IBD Study Group. Extraintestinal manifestations in Crohn's disease and ulcerative colitis: results from a prospective, population-based European inception cohort. Scand J Gastroenterol 2015;50:300-5. [PMID: 25535653 DOI: 10.3109/00365521.2014.991752] [Cited by in Crossref: 65] [Cited by in F6Publishing: 62] [Article Influence: 8.1] [Reference Citation Analysis]
55 Jørgensen KK, Lindström L, Cvancarova M, Castedal M, Friman S, Schrumpf E, Foss A, Isoniemi H, Nordin A, Holte K. Colorectal neoplasia in patients with primary sclerosing cholangitis undergoing liver transplantation: a Nordic multicenter study. Scand J Gastroenterol. 2012;47:1021-1029. [PMID: 22577871 DOI: 10.3109/00365521.2012.685754] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 3.5] [Reference Citation Analysis]
56 Liu K, Strasser SI, Koorey DJ, Leong RW, Solomon M, McCaughan GW. Interactions between primary sclerosing cholangitis and inflammatory bowel disease: implications in the adult liver transplant setting. Expert Rev Gastroenterol Hepatol 2017;11:949-60. [PMID: 28627935 DOI: 10.1080/17474124.2017.1343666] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
57 Tanaka A, Mertens JC. Ulcerative Colitis with and without Primary Sclerosing Cholangitis: Two Different Diseases? Inflamm Intest Dis 2016;1:9-14. [PMID: 29922654 DOI: 10.1159/000445259] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
58 Fattahi MR, Malek-Hosseini SA, Sivandzadeh GR, Safarpour AR, Bagheri Lankarani K, Taghavi AR, Ejtehadi F. Clinical Course of Ulcerative Colitis After Liver Transplantation in Patients with Concomitant Primary Sclerosing Cholangitis and Ulcerative Colitis. Inflamm Bowel Dis. 2017;23:1160-1167. [PMID: 28520586 DOI: 10.1097/mib.0000000000001105] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
59 Hov JR, Boberg KM, Taraldsrud E, Vesterhus M, Boyadzhieva M, Solberg IC, Schrumpf E, Vatn MH, Lie BA, Molberg Ø, Karlsen TH. Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis. Liver Int 2017;37:458-65. [PMID: 27558072 DOI: 10.1111/liv.13238] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
60 Umetsu S, Notohara K, Nakazawa T, Tsunoda T, Sogo T, Komatsu H, Tanaka A, Tazuma S, Takikawa H, Inui A, Fujisawa T. Long-term outcomes of pediatric-onset primary sclerosing cholangitis: A single-center experience in Japan. Hepatol Res 2019;49:1386-97. [PMID: 31408920 DOI: 10.1111/hepr.13421] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
61 Geboes K, Dewit O, Moreels TG, Faa G, Jouret-mourin A. Inflammatory Bowel Diseases. In: Jouret-mourin A, Faa G, Geboes K, editors. Colitis. Cham: Springer International Publishing; 2018. pp. 107-40. [DOI: 10.1007/978-3-319-89503-1_8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Kővári B, Báthori Á, Friedman MS, Lauwers GY. Histologic Diagnosis of Inflammatory Bowel Diseases. Adv Anat Pathol 2022;29:48-61. [PMID: 34879038 DOI: 10.1097/PAP.0000000000000325] [Reference Citation Analysis]
63 Block M, Jørgensen KK, Oresland T, Lindholm E, Grzyb K, Cvancarova M, Vatn MH, Boberg KM, Börjesson L. Colectomy for patients with ulcerative colitis and primary sclerosing cholangitis - what next? J Crohns Colitis. 2014;8:421-430. [PMID: 24239402 DOI: 10.1016/j.crohns.2013.10.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
64 Lindström L, Jørgensen KK, Boberg KM, Castedal M, Rasmussen A, Rostved AA, Isoniemi H, Bottai M, Bergquist A. Risk factors and prognosis for recurrent primary sclerosing cholangitis after liver transplantation: a Nordic Multicentre Study. Scand J Gastroenterol 2018;53:297-304. [PMID: 29301479 DOI: 10.1080/00365521.2017.1421705] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
65 de Vries AB, Janse M, Blokzijl H, Weersma RK. Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis. World J Gastroenterol 2015; 21(6): 1956-1971 [PMID: 25684965 DOI: 10.3748/wjg.v21.i6.1956] [Cited by in CrossRef: 89] [Cited by in F6Publishing: 68] [Article Influence: 12.7] [Reference Citation Analysis]
66 Eaton JE, Talwalkar JA, Lazaridis KN, Gores GJ, Lindor KD. Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management. Gastroenterology 2013;145:521-36. [PMID: 23827861 DOI: 10.1053/j.gastro.2013.06.052] [Cited by in Crossref: 223] [Cited by in F6Publishing: 196] [Article Influence: 24.8] [Reference Citation Analysis]
67 Cordes F, Laumeyer T, Gerß J, Brückner M, Lenze F, Nowacki T, Rijcken E, Tepasse P, Schmidt H, Kucharzik T, Bettenworth D. Distinct Disease Phenotype of Ulcerative Colitis in Patients With Coincident Primary Sclerosing Cholangitis: Evidence From a Large Retrospective Study With Matched Cohorts. Diseases of the Colon & Rectum 2019;62:1494-504. [DOI: 10.1097/dcr.0000000000001496] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
68 Beheshti-Maal A, Tamimi A, Iravani S, Memarnejadian A, Sorouri M, Aghdaei HA, Zali MR, Hossein Khannazer N, Vosough M. PSC associated inflammatory bowel disease: A distinct entity. Expert Rev Gastroenterol Hepatol 2022. [PMID: 35078376 DOI: 10.1080/17474124.2022.2031979] [Reference Citation Analysis]
69 Raszeja-wyszomirska J, Wunsch E, Krawczyk M, Rigopoulou EI, Bogdanos D, Milkiewicz P. Prospective evaluation of PBC-specific health-related quality of life questionnaires in patients with primary sclerosing cholangitis. Liver Int 2015;35:1764-71. [DOI: 10.1111/liv.12730] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
70 Mouchli MA, Singh S, Boardman L, Bruining DH, Lightner AL, Rosen CB, Heimbach JK, Hasan B, Poterucha JJ, Watt KD, Kane SV, Raffals LE, Loftus EV. Natural History of Established and De Novo Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis. Inflamm Bowel Dis. 2018;24:1074-1081. [PMID: 29522202 DOI: 10.1093/ibd/izx096] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
71 Jørgensen KK, Lindström L, Cvancarova M, Karlsen TH, Castedal M, Friman S, Schrumpf E, Foss A, Isoniemi H, Nordin A, Holte K, Rasmussen A, Bergquist A, Vatn MH, Boberg KM. Immunosuppression After Liver Transplantation for Primary Sclerosing Cholangitis Influences Activity of Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology 2013;11:517-23. [DOI: 10.1016/j.cgh.2012.12.027] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 4.2] [Reference Citation Analysis]
72 Yarur AJ, Czul F, Levy C. Hepatobiliary manifestations of inflammatory bowel disease. Inflamm Bowel Dis. 2014;20:1655-1667. [PMID: 24874461 DOI: 10.1097/mib.0000000000000065] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]